I don’t know how they calculated the $190M inven
Post# of 148320
(Total Views: 425)
Posted On: 05/03/2019 12:35:08 AM
I don’t know how they calculated the $190M inventory noted at NC in January, but they have consistently used $200M total inventory based on $120,000 per patient per year. Only recently did they break out the commercial grade product they had on hand. One PI video I noted in my last post specifically stated this. I wish I could located another recent video in which NP stated that the $50M was both commercial and P3 grade product.
Maybe I was wrong in my previous response to ohm on the $50M and $62M commercial product NP stated today. Maybe this is simply based on the reduced quantity of 700mg vs 525mg? This aligns with the math as 25% reduction in quantity equals 25% more inventory batches ($62.5M worth of 525mg vs $50M worth of 700mg if prices the same).
Maybe I was wrong in my previous response to ohm on the $50M and $62M commercial product NP stated today. Maybe this is simply based on the reduced quantity of 700mg vs 525mg? This aligns with the math as 25% reduction in quantity equals 25% more inventory batches ($62.5M worth of 525mg vs $50M worth of 700mg if prices the same).
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼